Add Sorry, i don't Understand
@@ -0,0 +1,7 @@
|
||||
<br>Sorry, I don't understand. Chesterbrook, Pennsylvania, [GlycoCares.netbitter melon extract](https://worldaid.eu.org/discussion/profile.php?id=2129266) October 24, 2017-New research published in two leading diabetes journals demonstrated accuracy and reliability of the OneTouch Verio Flex® blood glucose monitoring (BGM) system, and when the system was used with the OneTouch Reveal® mobile app, it was associated with significant improvements in glycemic control. In a study just published in the [Journal](https://data.gov.uk/data/search?q=Journal) of Diabetes Science and Technology, leading experts in self-monitoring of blood glucose (BG) tested the OneTouch Verio Flex® blood glucose monitoring system and found that the "new system showed a high level of measurement accuracy." All three lots tested met and exceeded the minimum requirements of the International Organization for Standardization (ISO) 15197:2013 standard for system accuracy. This study follows the publication of another study in the April issue of this same journal that detailed the OneTouch Verio® platform’s seven years of proven accuracy across more than 70,000 clinical data points. Those who were in the OneTouch Reveal® mobile app group also received texts from a healthcare provider every two weeks, based on a review of OneTouch Reveal® data.<br>
|
||||
|
||||
<br>Improvements using the app were greatest in the participants with type 2 diabetes and those who received the highest number of healthcare provider text messages. "Use of the OneTouch Verio Flex® meter alone or in combination with the OneTouch Reveal® app was associated with significant improvements in glycemic control after 12 and 24 weeks," the study authors noted. Smart Technology. This connectivity enables users to see their blood glucose readings on the mobile app, on their smart device and on their computer through the OneTouch Reveal® web app, and also makes it easier than ever for [GlycoCares.netbitter melon extract](https://www.curry-pot.com/general/can-stress-and-anxiety-cause-high-blood-sugar/) patients to share their data with their healthcare teams (see infographic). Both the OneTouch Reveal® mobile and web apps visually utilize the same colors as the OneTouch Verio Flex® meter with ColorSure® technology, which uses color to quickly tell the user if a glucose value is in range (green) or above (red) or below (blue) range.<br>
|
||||
|
||||
<br>"Self-monitoring of blood glucose is still the most accurate, effective and accessible way people with diabetes can track their blood sugars," says Dr. Brian Levy, Chief Medical Officer, LifeScan, Inc. "With the OneTouch Verio Flex® blood glucose monitoring system, we are proud to offer people with diabetes and their care teams a very accurate system that they know they can trust. Building on that accuracy, we now have our interconnected diabetes management OneTouch Reveal® system that changes the way patients see their blood sugar. 1 downloaded diabetes app in the U.S., Canada, France, and the U.K. The new version of the OneTouch Reveal® mobile app is available now as a free download for Apple® devices on the App Store® and Android™ devices on Google Play™ in 11 countries globally, including the U.S., Austria, Belgium, Canada, France, Germany, Italy, Ireland, Portugal, Spain, and the United Kingdom. The OneTouch Reveal® mobile app and OneTouch Verio Flex® blood glucose monitoring system are offerings from the iconic OneTouch® brand by LifeScan, Inc., part of the Johnson & Johnson Diabetes Care Companies and a world leader in blood glucose monitoring.<br>
|
||||
|
||||
<br>With a shared vision of creating a world without limits for people with diabetes, the Johnson & Johnson Diabetes Care Companies are a collaboration of Johnson & Johnson companies dedicated to diabetes and includes LifeScan, Inc., a world leader in blood glucose monitoring; Calibra Medical, Inc., developer of OneTouch Via™ on-demand insulin delivery; and the Johnson & Johnson Diabetes Institute, LLC, a global initiative to improve care and better outcomes worldwide through education and training programs. In the U.S., LifeScan, Inc. is the leading blood glucose monitoring company and OneTouch® brand products are recommended by more endocrinologists and primary care physicians than any other brand. Globally, more than 20 million people depend on OneTouch® brand products to help them manage their diabetes. Setford, et al. Seven-year surveillance of the clinical performance of a blood glucose test strip product. Grady, et al. Diabetes App-Related Text Messages from Health Care Professionals in Conjunction with a New Wireless Glucose Meter With a Color Range Indicator Improves Glycemic Control in Patients With Type 1 and Type 2 Diabetes: Randomized Controlled Trial. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by LifeScan Scotland Ltd. Other trademarks and trade names are those of their respective owners.<br>
|
||||
Reference in New Issue
Block a user